Variant report
Variant | nsv559579 |
---|---|
Chromosome Location | chr12:84564068-84593586 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:86)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr12:84575615-84575954 | HepG2 | liver: | n/a | chr12:84575790-84575801 |
2 | CEBPB | chr12:84575648-84575974 | IMR90 | lung: | n/a | chr12:84575790-84575801 |
3 | CEBPB | chr12:84566641-84566838 | K562 | blood: | n/a | n/a |
4 | CEBPB | chr12:84575678-84575942 | H1-hESC | embryonic stem cell: | n/a | chr12:84575790-84575801 |
5 | CEBPB | chr12:84566658-84566951 | HepG2 | liver: | n/a | n/a |
6 | CEBPB | chr12:84566633-84566888 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | CEBPB | chr12:84566615-84566974 | ECC-1 | luminal epithelium: | n/a | n/a |
8 | CEBPB | chr12:84566621-84566945 | Hela-S3 | cervix: | n/a | n/a |
9 | CEBPB | chr12:84575641-84575858 | A549 | lung: | n/a | chr12:84575790-84575801 |
10 | CTCF | chr12:84574150-84574183 | Lung_OC | lung: | n/a | n/a |
11 | CTCF | chr12:84566972-84567047 | MCF-7 | breast: | n/a | n/a |
12 | CTCF | chr12:84566942-84567001 | MCF-7 | breast: | n/a | n/a |
13 | CTCF | chr12:84567817-84567880 | Fibrobl | skin: | n/a | n/a |
14 | E2F4 | chr12:84571702-84571850 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | E2F4 | chr12:84583913-84583956 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | EP300 | chr12:84579835-84580754 | SK-N-SH | brain: | n/a | n/a |
17 | EP300 | chr12:84579885-84580873 | SK-N-SH | brain: | n/a | n/a |
18 | EP300 | chr12:84584808-84585103 | SK-N-SH_RA | brain: | n/a | n/a |
19 | EP300 | chr12:84579965-84580860 | SK-N-SH | brain: | n/a | n/a |
20 | EP300 | chr12:84579954-84580612 | SK-N-SH_RA | brain: | n/a | n/a |
21 | EP300 | chr12:84579907-84580671 | SK-N-SH_RA | brain: | n/a | n/a |
22 | FOSL2 | chr12:84580016-84580730 | SK-N-SH | brain: | n/a | n/a |
23 | FOXM1 | chr12:84580127-84580698 | SK-N-SH | brain: | n/a | n/a |
24 | FOXM1 | chr12:84580208-84580679 | SK-N-SH | brain: | n/a | n/a |
25 | GATA2 | chr12:84580236-84580509 | SH-SY5Y | brain: | n/a | n/a |
26 | GATA3 | chr12:84579976-84580774 | SK-N-SH | brain: | n/a | n/a |
27 | GATA3 | chr12:84579876-84580843 | SK-N-SH | brain: | n/a | n/a |
28 | GATA3 | chr12:84578622-84578773 | SH-SY5Y | brain: | n/a | n/a |
29 | GATA3 | chr12:84564153-84564313 | SH-SY5Y | brain: | n/a | n/a |
30 | GATA3 | chr12:84580387-84580493 | SH-SY5Y | brain: | n/a | n/a |
31 | JUND | chr12:84579967-84580721 | SK-N-SH | brain: | n/a | n/a |
32 | JUND | chr12:84580040-84580748 | SK-N-SH | brain: | n/a | n/a |
33 | MAFK | chr12:84569018-84569102 | HepG2 | liver: | n/a | n/a |
34 | MAZ | chr12:84573352-84573400 | HepG2 | liver: | n/a | n/a |
35 | MYC | chr12:84566883-84566884 | MCF-7 | breast: | n/a | n/a |
36 | MYC | chr12:84566925-84567025 | MCF-7 | breast: | n/a | n/a |
37 | MYC | chr12:84571453-84571647 | MCF10A-Er-Src | breast: | n/a | n/a |
38 | MYC | chr12:84587913-84587921 | MCF10A-Er-Src | breast: | n/a | n/a |
39 | MYC | chr12:84566892-84567120 | MCF-7 | breast: | n/a | n/a |
40 | MYC | chr12:84568105-84568266 | H1-hESC | embryonic stem cell: | n/a | n/a |
41 | MYC | chr12:84568037-84568217 | MCF-7 | breast: | n/a | n/a |
42 | MYC | chr12:84566898-84567075 | MCF-7 | breast: | n/a | n/a |
43 | MYC | chr12:84567032-84567052 | MCF-7 | breast: | n/a | n/a |
44 | NFIC | chr12:84579908-84580870 | SK-N-SH | brain: | n/a | n/a |
45 | NFIC | chr12:84580107-84580598 | SK-N-SH | brain: | n/a | n/a |
46 | PBX3 | chr12:84580025-84580695 | SK-N-SH | brain: | n/a | n/a |
47 | PBX3 | chr12:84579842-84580765 | SK-N-SH | brain: | n/a | n/a |
48 | POLR2A | chr12:84567156-84567168 | A549 | lung: | n/a | n/a |
49 | POLR2A | chr12:84588901-84589141 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr12:84567993-84567997 | A549 | lung: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:84592646..84594505-chr12:84594640..84596287,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000221148 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs140200987 | chr12:84566840-84566841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536277015 | chr12:84566847-84566848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2929820 | chr12:84566875-84566876 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs534746911 | chr12:84566919-84566920 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs149894191 | chr12:84566929-84566930 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs144945418 | chr12:84566931-84566932 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs149092981 | chr12:84566940-84566941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs557613369 | chr12:84566993-84566994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114465842 | chr12:84567018-84567019 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs192764750 | chr12:84567038-84567039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs572677565 | chr12:84567042-84567043 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572978130 | chr12:84567048-84567049 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs540295271 | chr12:84567056-84567057 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561898099 | chr12:84567068-84567069 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529061765 | chr12:84567124-84567125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs370351620 | chr12:84567130-84567131 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs562789459 | chr12:84567154-84567155 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533036231 | chr12:84567157-84567158 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs552153355 | chr12:84567165-84567166 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs546467486 | chr12:84567206-84567207 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183619819 | chr12:84567222-84567223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs534809590 | chr12:84567229-84567230 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546676396 | chr12:84567233-84567234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs568591035 | chr12:84567273-84567274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75011294 | chr12:84567274-84567275 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs557411017 | chr12:84567275-84567276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs188318342 | chr12:84567307-84567308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540092253 | chr12:84567378-84567379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs557801961 | chr12:84567380-84567381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572860570 | chr12:84567412-84567413 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147854136 | chr12:84567457-84567458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561762268 | chr12:84567486-84567487 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs141407645 | chr12:84567562-84567563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147036506 | chr12:84567572-84567573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs2403183 | chr12:84567611-84567612 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs576911800 | chr12:84567635-84567636 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2403184 | chr12:84567642-84567643 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs551229963 | chr12:84567656-84567657 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs148075501 | chr12:84567681-84567682 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150232304 | chr12:84567714-84567715 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546738339 | chr12:84567780-84567781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577867842 | chr12:84567832-84567833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568533761 | chr12:84567852-84567853 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78196100 | chr12:84567857-84567858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs551157113 | chr12:84567871-84567872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs367869391 | chr12:84567876-84567877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142183248 | chr12:84567882-84567883 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181757207 | chr12:84567896-84567897 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2086622 | chr12:84567897-84567898 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs560277516 | chr12:84567948-84567949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17899364 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
abnormal development | 18461090 | CNVD |
Prostate cancer | 18632612 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 22032731 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:84566800-84567000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr12:84566800-84567000 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
3 | chr12:84566800-84567200 | Enhancers | HMEC | breast |
4 | chr12:84567000-84569800 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
5 | chr12:84577000-84577200 | Enhancers | Fetal Heart | heart |
6 | chr12:84577000-84578000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr12:84577000-84578000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
8 | chr12:84577000-84578000 | Enhancers | NHEK | skin |
9 | chr12:84577000-84578200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr12:84577200-84578000 | Flanking Active TSS | Fetal Heart | heart |
11 | chr12:84578000-84579000 | Active TSS | Fetal Heart | heart |
12 | chr12:84578000-84585800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr12:84585200-84586400 | Enhancers | HMEC | breast |
14 | chr12:84585600-84586400 | Enhancers | NHEK | skin |
15 | chr12:84585800-84586600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |